Literature DB >> 10462342

Etiology of acute lower respiratory tract infection in Central Australian Aboriginal children.

P Torzillo1, J Dixon, K Manning, S Hutton, M Gratten, L Hueston, M Leinonen, F Morey, S Forsythe, R Num, J Erlich, V Asche, A Cunningham, I Riley.   

Abstract

BACKGROUND: Aboriginal children in central Australia have attack rates for acute lower respiratory tract infection (ALRI) that are similar to those in developing countries. Although mortality rates are much lower than in developing countries, morbidity is high and ALRI is still the leading cause of hospitalization. However, there are no data on the etiology of ALRI in this population.
METHODS: We prospectively studied 322 cases of ALRI in 280 Aboriginal children admitted to the hospital. Blood, urine and nasopharyngeal aspirate samples were examined for evidence of bacterial, viral and chlamydial infection.
RESULTS: The combination of blood culture, viral studies and chlamydial serology provided at least 1 etiologic agent in 170 of 322 (52.5%) cases. Assays for pneumolysin immune complex and pneumolysin antibody increased etiologic diagnosis to 219 (68.0%). Blood cultures were positive in 6% but pneumolysin immune complex and pneumolysin antibody studies were positive in one-third of cases. Evidence of viral infection was present in 155 (48%) of cases compared with 12% in controls (P < 001). There were only 7 possible cases and 2 definite cases of Chlamydia trachomatis and 3 cases of Chlamydia pneumoniae. Coinfection was common in these children.
CONCLUSION: These findings have implications for both standard treatment protocols and vaccine strategies. The high rate of coinfection may make it difficult to develop simple clinical predictors of bacterial infection. In the setting of a developed country with efficient patient evacuation services, management algorithms that focus on disease severity and need for hospital referral will be most useful to health staff in remote communities. Pneumococcal conjugate vaccines will be required to reduce the high attack rate of pneumococcal disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10462342     DOI: 10.1097/00006454-199908000-00012

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  15 in total

1.  Serodiagnosis of acute respiratory infections in children in Georgia.

Authors:  I Chkhaidze; N Manjavidze; K Nemsadze
Journal:  Indian J Pediatr       Date:  2006-07       Impact factor: 1.967

2.  The study protocol for a randomized controlled trial of a family-centred tobacco control program about environmental tobacco smoke (ETS) to reduce respiratory illness in Indigenous infants.

Authors:  Vanessa Johnston; Natalie Walker; David P Thomas; Marewa Glover; Anne B Chang; Chris Bullen; Peter Morris; Ngiare Brown; Stephen Vander Hoorn; Ron Borland; Catherine Segan; Adrian Trenholme; Toni Mason; Debra Fenton; Kane Ellis
Journal:  BMC Public Health       Date:  2010-03-07       Impact factor: 3.295

3.  Effectiveness of 7-valent pneumococcal conjugate vaccine against radiologically diagnosed pneumonia in indigenous infants in Australia.

Authors:  K F O'Grady; J B Carlin; A B Chang; P J Torzillo; T M Nolan; A Ruben; R M Andrews
Journal:  Bull World Health Organ       Date:  2009-12-08       Impact factor: 9.408

4.  Prevalence of and risk factors for human rhinovirus infection in healthy aboriginal and non-aboriginal Western Australian children.

Authors:  Alicia A Annamalay; Siew-Kim Khoo; Peter Jacoby; Joelene Bizzintino; Guicheng Zhang; Glenys Chidlow; Wai-Ming Lee; Hannah C Moore; Gerry B Harnett; David W Smith; James E Gern; Peter N LeSouef; Ingrid A Laing; Deborah Lehmann
Journal:  Pediatr Infect Dis J       Date:  2012-07       Impact factor: 2.129

5.  Disease burden and health-care clinic attendances for young children in remote aboriginal communities of northern Australia.

Authors:  Danielle B Clucas; Kylie S Carville; Christine Connors; Bart J Currie; Jonathan R Carapetis; Ross M Andrews
Journal:  Bull World Health Organ       Date:  2008-04       Impact factor: 9.408

Review 6.  Pneumococcal serology in children's respiratory infections.

Authors:  M Korppi; M Leinonen; O Ruuskanen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12-18       Impact factor: 3.267

7.  Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review.

Authors:  Kimberly Bloom-Feshbach; Wladimir J Alonso; Vivek Charu; James Tamerius; Lone Simonsen; Mark A Miller; Cécile Viboud
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

Review 8.  Chlamydia psittaci (psittacosis) as a cause of community-acquired pneumonia: a systematic review and meta-analysis.

Authors:  L Hogerwerf; B DE Gier; B Baan; W VAN DER Hoek
Journal:  Epidemiol Infect       Date:  2017-09-26       Impact factor: 4.434

9.  Role of human metapneumovirus, influenza A virus and respiratory syncytial virus in causing WHO-defined severe pneumonia in children in a developing country.

Authors:  Asad Ali; Asif Raza Khowaja; Maaman Zahoor Bashir; Fatima Aziz; Sultan Mustafa; Anita Zaidi
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

10.  A single dose of azithromycin does not improve clinical outcomes of children hospitalised with bronchiolitis: a randomised, placebo-controlled trial.

Authors:  Gabrielle B McCallum; Peter S Morris; Mark D Chatfield; Carolyn Maclennan; Andrew V White; Theo P Sloots; Ian M Mackay; Anne B Chang
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.